Your browser doesn't support javascript.
loading
Epigenetic suppression of PGC1α (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas.
Liang, Jiaxin; Yu, Deyang; Luo, Chi; Bennett, Christopher; Jedrychowski, Mark; Gygi, Steve P; Widlund, Hans R; Puigserver, Pere.
Afiliação
  • Liang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Yu D; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • Luo C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bennett C; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • Jedrychowski M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • Widlund HR; Parthenon Therapeutics, Boston, MA, 02135, USA.
  • Puigserver P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Commun ; 14(1): 3251, 2023 06 05.
Article em En | MEDLINE | ID: mdl-37277330
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article